Nevada – Harbor Healthcare is pleased to announce the sale and partnership of Meta Pharmacy Services, a distinguished 503A nationwide compounding pharmacy providing advanced anti-aging and integrative therapies. The acquirer, a private investor, brings further resources and acumen to the pharmacy. The collaboration signifies a pivotal advancement for the company; one that will foster growth and innovation for patients and providers across the nation.
Meta Pharmacy Services garnered recognition as a leader in the sector by developing innovative formulations, integrated medication management, technological solutions, and exceptional patient support. As a sterile compounding pharmacy, the business remains dedicated to crafting personalized therapeutic regimens in hormone therapy, anti-aging, weight loss and integrative therapies. This strategic partnership highlights the company’s history of excellence and its continued trajectory as the market leader in compounding pharmacy services.
A Transformative Chapter in Compounding Pharmacy Care
“We are honored to unveil this transformative chapter for Meta Pharmacy Services,” said Sean Barclay, CEO of Meta Pharmacy Services. “The acquirer’s strategic partnership underscores their trust in our clinical expertise and vision. Our collaboration enables us to enhance our operational capabilities, broaden our technological services, and extend our specialized solutions to an even wider demographic of patients and healthcare providers.”
The investor group is a combination of two family offices that contribute a wealth of strategic healthcare expertise and a forward-looking vision for growth. The group’s ability to access emerging markets, foster robust collaborations with healthcare providers, and articulate a renewed strategic direction will catalyze Meta Pharmacy Services’ expansion.
Unwavering Commitment to Excellence and Innovation
“We are in the midst of a growth phase of compounding pharmacy. Acquirer activity is at peak levels for sterile and nonsterile 503A and 503B pharmacies. There are remarkable opportunities for owners to monetize their business and concurrently experience exponential growth via a strategic investment or partnership. There are numerous drivers contributing to this record-setting activity, but none as important as great service to patients and providers. Unmatched service is the blueprint for Meta Pharmacy Services’ new partnership, and we are very excited to watch the business grow.” said Mark Alford, managing director at Harbor Healthcare.
The transition to a new partnership will maintain the seamless delivery of services and collaborations that Meta Pharmacy Services’ stakeholders have come to expect. The company’s existing leadership and clinical teams will continue to uphold the highest standards of care, ensuring consistent delivery and innovation. Backed by the new strategic investor, Meta Pharmacy Services is positioned to accelerate its investments in advanced methodologies, expand its network of healthcare professionals, and pursue opportunities in underrepresented markets across the nation.
About Meta Pharmacy Services
Meta Pharmacy Services is the preeminent provider of compounding pharmacy solutions, dedicated to advancing patient health through precision care, technological innovation, and unparalleled service. The company specializes in compounded oral, sublingual, topical and injectable dosage forms. The pharmacy is licensed in over 35 states that enables it to serve a broad spectrum of clients across the country.
About the Investor Group
The investor group is a combination of two family offices that excel in fostering enduring growth through strategic investments across healthcare, technology, and ancillary sectors. Prioritizing innovation and sustainability, they collaborate with enterprises to drive meaningful advancements for the sectors they exist in. Their robust access to new markets, extensive provider networks, and strategic vision ensure that their investments cultivate long-term success coupled with community benefits.
About Harbor Healthcare
Harbor Healthcare is a boutique M&A advisory firm offering services to middle market healthcare organizations and specializing in compounding pharmacy since 1995. The company provides perceptive strategic solutions to independent owners and investors of long-term care, specialty, home infusion, compounding (503A and 503B) and 340B pharmacies. A pharmacist-founded firm comprised of bankers and healthcare entrepreneurs, Harbor offers unparalleled regulatory and advisory expertise while maintaining unshakeable business relationships with strategic, private equity and independent acquirers. For more information, please contact Mark Alford, Managing Director at Harbor Healthcare (619) 535-9005 or visit https://www.harborhealthcare.com.
Click Here for a Sample of Our M&A Transactions
Select Transactions